To main content To navigation

Life Sciences

Advanced In Vitro Models – Organoids meet organs-on-a-chip

When:

13 July - 17 July 2026

School:

Utrecht Summer School

Institution:

Utrecht Summer School

City:

Utrecht

Country:

Netherlands

Language:

English

Credits:

1.5 EC

Fee:

1000 EUR

Interested?
Advanced In Vitro Models – Organoids meet organs-on-a-chip

About

Through collaboration with Ombion, the Netherlands’ national centre for animal-free biomedical translation, you will explore how organoids, organs-on-chips, and advanced in vitro technologies are redefining safety, drug development and regenerative medicine.

Organoids Meet Organs-on-Chips – in collaboration with Ombion
Advanced in vitro models (AIM) are transforming biomedical science. By recreating physiologically relevant, in vivo-like tissues and organ systems, AIM technologies improve predictive accuracy, accelerate innovation, and reduce the need for animal experimentation. This year, the AIM Summer School is organized in close collaboration with Ombion, the Dutch national centre for human-based testing strategies. Ombion contributes expertise in human-relevant in vitro platforms, regulatory science, and the translation of cutting-edge models into predictive testing pipelines. Through this partnership, participants gain unique insight into how novel AIM technologies are implemented in academic, industrial, and regulatory decision-making.

Course Overview
During this intensive week-long programme in Utrecht, you will explore the convergence of science, technology, legislation and extrapolation modelling that shapes the future of human-based research. The course combines expert lectures, hands-on laboratory sessions, computational modelling, demonstrations, and site visits—offering a comprehensive and practice-oriented introduction to the AIM landscape. Working alongside Ombion specialists and international experts, you will learn how organoids, organs-on-chips, and enabling technologies are developed, validated and applied in biomedical research and regulatory contexts.

Course leader

Dr. Silvia Mihăilă & Dr. Kerstin Schneeberger

Target group

This course is designed for Master’s students, PhD candidates, early-career researchers, and professionals from academia and industry who are beginning their journey in the field of advanced in vitro models, including organoids, organs-on-chips, and human-relevant testing strategies.

It is ideal for participants with a background or interest in:

Cell biology, stem cell biology, pharmacology, toxicology
Biomedical sciences, (bio)engineering, tissue engineering
Model development, preclinical innovation, and translational research
Implementing or transitioning towards animal-free, human-relevant methods
Whether you are an academic researcher exploring next-generation model systems or an industry professional seeking to integrate in vitro innovations into R&D pipelines, this course provides the scientific foundation, hands-on skills, and regulatory insight needed to advance in this rapidly developing field.

Course aim

The AIM Summer School offers a unique, interdisciplinary view of how next-generation in vitro models are shaping the future of science and medicine. With Ombion as a key partner, the programme provides:

Stronger focus on translation and regulatory relevance
Insight into industry-aligned workflows and human-based testing strategies
Understanding of AIM technologies within national and European animal-free innovation ecosystems
Participants leave with a solid scientific foundation, hands-on technical skills, and strategic insight—preparing them to contribute to the rapidly advancing field of human-relevant in vitro modelling.

Fee info

Fee

1000 EUR, course + course materials

Fee

275 EUR, Housing fee (optional)

Interested?

When:

13 July - 17 July 2026

School:

Utrecht Summer School

Institution:

Utrecht Summer School

Language:

English

Credits:

1.5 EC

Visit school

Stay up-to-date about our summer schools!

If you don’t want to miss out on new summer school courses, subscribe to our monthly newsletter.